Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes

Publication | Closed Access

DOI

Citations

References

2003

Year

Elizabeth Barrett‐Connor, Kristine E. Ensrud, Kristine D. Harper, Timothy M. Mason, Andreas Sashegyi, Kathryn A. Krueger, Pamela W. Anderson

Clinical Therapeutics

Diabetes ManagementCardiovascular DiseaseDiabetesRaloxifene EvaluationClinical TrialsOutcomes ResearchRaloxifene TreatmentPharmacotherapyDiabetes MellitusPublic HealthPost Hoc AnalysisMedicineEpidemiologyPharmacoepidemiology